Innoviva Appoints Eric D’Esparbes As Co’s Interim Principal Executive Officer
SEC FILING
Name: Michael W. Aguiar
Continent: North America
Country: USA
Company: Innoviva
Branch: Pharma
Position: CEO
Reason: Resigned
Announcement Date: February 06, 2018, 11:00pm
Resignation Date: February 06, 2018, 11:00pm